CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

BRANFORD, Conn., June 6 CuraGen Corporation(Nasdaq: CRGN) announced today that Dr. Timothy Shannon, President and ChiefExecutive Officer, will present at The Seventh Annual Needham & CompanyBiotechnology and Medical Technology Conference on Wednesday, June 11, 2008,at 3:30 p.m. Eastern time. The conference is being held at the New YorkPalace Hotel in New York, NY.

Access to a live webcast of the presentation will be available from theInvestor Relations section of CuraGen's website at http://www.curagen.com. Areplay of the webcast will be available after the presentation and archivedfor 30 days thereafter.

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a clinical-stage biopharmaceuticalcompany developing promising approaches for the treatment of cancer. CuraGenCorporation is headquartered in Branford, Connecticut. For additionalinformation please visit http://www.curagen.com.CuraGen Contact: Glenn Schulman, Pharm.D. Director Medical Communications [email protected] (888) 436-6642 CRGN-G

SOURCE CuraGen Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...